Search By Initial

Cas Index 2

• 2086772-26-9 | JNJ-64619178 (Catalog# : 193292)JNJ-64619178是一种候选的抗癌药物。
• 259869-55-1 | JWH-133 (Catalog# : 6111109)JWH 133 is a potent CB2 selective agonist with Ki of 3.4 nM, 200-fold selective over
• 202475-60-3 | JANEX-1 (Catalog# : 52220)Janex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibi
• 2416873-83-9 | KB-0742 (Catalog# : 24040)KB-0742 是一种有效的，选择性的和具有口服活性的 CDK9 抑制剂。
• 2416874-75-2 | KB-0742 dihydrochloride (Catalog# : 24020)KB-0742 是一种有效的、选择性的、口服生物可利用的 CDK9 小分子抑
• 2082765-42-0 | KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) (Catalog# : 20641)KP-302 ( Synonyms: Lucid-21-302 ; Lucid-MS ) 是一种蛋白质精氨酸脱亚胺酶的
• 2446480-97-1 | KSQ-4279 (Catalog# : 20472)KSQ-4279 is a USP1 and PARP inhibitor. KSQ-4279 showed anti-proliferative effects in
• 2226664-93-1 | KY19382 (Catalog# : L20334)KY19382 is an orally active dual inhibitor of CXXC5-DVL and GSK3β
• 228559-41-9 | Ki8751 (Catalog# : 17022703)Ki8751是一种强力的、选择性的VEGFR- 2酪氨酸激酶(IC50 = 0.9 nM)的抑制
• 286370-15-8 | KRN 633 (Catalog# : 51912)KRN 633 is an ATP-competitive inhibitor ofVEGFR1/2/3withIC50of 170 nM/160 nM/125 nM,
• 2247995-37-3 | Lazertinib mesylate (Catalog# : 25052)Lazertinib是一种口服的第三代选择性表皮生长因子受体（EGFR）抑制
• 2688040-45-9 | Lirafugratinib HCl (Catalog# : 24113)Lirafugratinib, also known as RLY-4008, is a tyrosine kinase inhibitor with potential
• 2251753-65-6 | LXH-3-71 (Catalog# : 24107)LXH-3-71是一种新型“分子胶”，可诱导PHGDH和DDB1-CUL4泛素连接酶之
• 2834106-06-6 | LTGO-33 (Catalog# : 24103)LTGO-33 is a selective, state-independent, and potent preclinical small molecule NaV1
• 2719793-90-3 | Lunresertib (Catalog# : 24080)Lunresertib, alsop known as RP-6306, is a potent and selective PKMYT1 inhibitor (IC50
• 2495096-26-7 | lartesertib (Catalog# : 24066)Lartesertib (M4076) is a potent inhibitor of serine/threonine protein kinase ATM (ext
• 297180-15-5 | Lipofermata (Catalog# : 24030)Lipofermata is a fatty acid transport protein 2(FATP2)inhibitor. Lipofermata shows fa
• 2568608-48-8 | LY3522348 (Catalog# : 20577)
• 244240-24-2 | LFM-A13 (Catalog# : 20438)LFM-A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK). LF
• 2375815-63-5 | LY-3475070 (Catalog# : 21244)LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alo
• 2097938-59-3 | Lerociclib HCl (G1T38 HCl) (Catalog# : 2073106)Lerociclib HCl (G1T38 dihydrochloride)是一种分化型口服CDK4 / 6抑制剂，对
• 2055050-87-6 | LAU159 (Catalog# : 2071505)LAU159 is a potent modulator of α6β3γ2 GABAA receptor.
• 294623-49-7 | L006235 (Catalog# : 2061307)L006235 is a potent, reversible cathepsin K inhibitor (IC50 = 0.25 nM) that displays
• 2274819-46-2 | LUT-014 (Catalog# : 2042701)LUT-014 is a B-Raf Inhibitor. Leveraging the paradoxical effect of B-Raf Inhibitors,
• 2135600-76-7 | LSZ102 (Catalog# : 2041502)LSZ102 is a potent ERα antagonist and degrader. LSZ102 showed ERα degradation IC50
• 2173037-97-1 | LY2794193 (Catalog# : 193262)LY2794193是一种高效选择性的mGlu3受体激动剂。
• 2166616-75-5 | LY-3381916 (Catalog# : 193123)LY-3381916是一种强效的、选择性的、脑透性的IDO1活性抑制剂，与缺
• 245075-84-7 | LR-90 (Catalog# : 19364)LR-90是一种晚期糖基化终产物(AGE)抑制剂，可抑制人单核细胞的炎
• 2222755-14-6 | LOXO-292 (Catalog# : 192195)LOXO-292 (ARRY-192)是一种口服和临床开发的选择性研究药物，用于治
• 292632-98-5 | L685458 (Catalog# : 186156)L685458是一个强有力的和选择性γ分泌酶抑制剂。